2021 annual financial data
4D Molecular Therapeutics 2021 Operating cash flow
4D Molecular Therapeutics 2021 operating cash flow with verified reported value…
Direct answer
Operating cash flow was -69,134,000 USD.
Operating income was -71,333,000 USD and net income was -68,297,000 USD.
Operating cash flow was -69,134,000 USD.
Get free 4D Molecular Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 18,038,000 USD
- Operating income
- -71,333,000 USD
- Net income
- -68,297,000 USD
- Operating cash flow
- -69,134,000 USD